Actigen (Norway)

Preparation of the alpha‐emitting prostate‐specific membrane antigen targeted radioligand [²¹²Pb]Pb‐NG001 for prostate cancer

Vilde Yuli Stenberg, Asta Juzeniene, Qingqi Chen et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2020 · 53 citations · Full text

In situ Generated ²¹²Pb-PSMA Ligand in a ²²⁴Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells

Vilde Yuli Stenberg, Asta Juzeniene, Øyvind S. Bruland et al. · Current Radiopharmaceuticals · 2020 · 28 citations · Full text

Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples

Elisa Napoli, Vilde Yuli Stenberg, Asta Juzeniene et al. · Applied Radiation and Isotopes · 2020 · 24 citations · Full text

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001

Vilde Yuli Stenberg, Anna Julie Kjøl Tornes, Hogne Røed Nilsen et al. · Cancers · 2022 · 21 citations · Full text